2025. HIGH-COST MEDICATIONS IN THE SUS: COPD PATIENTS IN A VULNERABLE STATE. Editora Impacto Científico. (Sep. 2025), 211–219. DOI:https://doi.org/10.56238/edimpacto2025.028-022.